Skip to content

Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease

Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04965545
Enrollment
1000
Registered
2021-07-16
Start date
2004-01-01
Completion date
2030-01-01
Last updated
2021-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilson Disease

Brief summary

The investigators aimed to identify factors associated with symptoms and features of Wilson disease from a large cohort during long-term follow-up

Detailed description

Wilson disease is an autosomal recessive disorder that impairs copper homeostasis and is caused by homozygous or compound heterozygous mutations in ATP7B, which encodes a copper-transporting P-type ATPase. Patients have variable clinical manifestations and laboratory test results, resulting in diagnostic dilemmas. Therefore, the investigators aimed to identify factors associated with symptoms and features of Wilson disease, thereby give timely diagnosis for patients.

Interventions

DIETARY_SUPPLEMENTlow copper diet

All patients with wilson disease should receive low copper diet

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* genetically diagnosed patients with wilson disease

Exclusion criteria

* Deny follow-up

Design outcomes

Primary

MeasureTime frameDescription
Serum ceruloplasminFrom 2004 through 2030Serum ceruloplasmin levels were collected among patients with wilson disease. After confirming a non-Gaussian distribution, the reference range of serum ceruloplasmin level was determined.
Urinary Copper ExcretionFrom 2004 through 2030The measurement of 24-hour urine copper excretions were collected and measured.
Kayser-Fleischer RingsFrom 2004 through 2030The presence of Kayser-Fleischer Rings among patients with wilson disease were confirmed via slit lamp.
Brain Magnetic Resonance ImagingFrom 2004 through 2030Brain Magnetic Resonance Imaging of all patients were collected and analyzed.

Countries

China

Contacts

Primary ContactYi Dong, Ph.D.
dongyi720@zju.edu.cn+8618367129345

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026